Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

Marie Skłodowska-Curie Action · Running

Fellows4Fungi Exploring fungal pathogens within unexplored microbial networks

Coordinator
Leibniz-Institut Fur Naturstoff-Forschung Und Infektionsbiologie eV Hans-Knoll-Institut, Germany
Runs
1 August 2026 to 31 July 2031
Status
Running
EU funding
€2.0m
Total cost
—
Partners
19 organisations in 7 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101261824

What the project is doing

In the project's own words, from its summary on CORDIS.

Fellows4Fungi is a prestigious international postdoctoral programme addressing the urgent global health challenge of fungal infections. Hosted by the Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute (LEIBNIZ-HKI) in Jena, Germany, the programme will recruit 12 top-tier researchers through two calls, offering 36-month fellowships that combine research freedom with structured, interdisciplinary training.

LEIBNIZ-HKI is Germany’s only academic centre dedicated to human-pathogenic fungi and a global leader in antifungal research and natural product discovery. Fellows will carry out pioneering work across six strategic research areas, ranging from AI-driven drug discovery and fungal pathogenesis to microbiome modelling and epigenetics. The programme’s scientific mission directly addresses the World Health Organization’s (WHO) call to action on fungal pathogens such as Aspergillus fumigatus and Candida albicans, which are rising in clinical relevance due to increasing antifungal resistance.

Fellows4Fungi offers access to cutting-edge infrastructure – including robotics platforms, high-performance computing, and a unique microbial strain collection -alongside secondments and mentoring with 18 leading academic, clinical, and biotech partners in 7 countries. The programme combines scientific excellence with a strong commitment to open science, equality, and responsible research, supporting fellows with competitive salaries, personalised career development, and an inclusive research environment.

Fellows4Fungi will train the next generation of leaders to bridge innovation gaps and drive advances in antifungal therapy, diagnostics, and data-driven healthcare solutions.

Topics

Who is involved

OrganisationCityCountryRole
Leibniz-Institut Fur Naturstoff-Forschung Und Infektionsbiologie eV Hans-Knoll-InstitutJenaGermanyCoordinator
Biofaction KgWienAustriaAssociatedpartner
Perseus BiomicsTienenBelgiumAssociatedpartner
Altona Diagnostics GmbHHamburgGermanyAssociatedpartner
Ascenion GmbHMunichGermanyAssociatedpartner
Analytik Jena Gmbh+Co.KGJenaGermanyAssociatedpartner
Biomarker Technologies (bmk) GmbHMunsterGermanyAssociatedpartner
Bright Giant GmbHJenaGermanyAssociatedpartner
Friedrich Loeffler Institut - Bundesforschungsinstitut Fuer TiergesundheitGreifswald-Insel RiemsGermanyAssociatedpartner
Friedrich-Schiller-Universität JenaJenaGermanyAssociatedpartner
Helmholtz-Zentrum Fur Infektionsforschung GmbHBraunschweigGermanyAssociatedpartner
Julius-Maximilians-Universitat WurzburgWuerzburgGermanyAssociatedpartner
Robert Koch-InstitutBerlinGermanyAssociatedpartner
SmartDyeLivery GmbHJenaGermanyAssociatedpartner
University of StuttgartStuttgartGermanyAssociatedpartner
Danmarks Tekniske UniversitetKongens LyngbyDenmarkAssociatedpartner
Ellinikos Georgikos Organismos - DimitraAthinaGreeceAssociatedpartner
Novogene Netherlands BVAmsterdamNetherlandsAssociatedpartner
E1 Datascience LtdBedfordUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI